AMSC vs BIO · P/E 14, rev $299.2M vs rev $651.0M
American Superconductor Corporation (AMSC) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
American Superconductor Corporation (AMSC) is a specialty industrial machinery company listed on US.
BIO (BIO) common stock.
Latest reported AMSC revenue for 2026-03-31 was $299.2M. Net income was $133.8M. Revenue was up 34.3% from 2025-03-31 to 2026-03-31. AMSC currently screens at market cap $2.02B and trailing P/E 13.9.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
AMSC currently screens at market cap $2.02B and trailing P/E 13.9. BIO currently screens at market cap $0.
Not investment advice. Open the AMSC and BIO stock pages for the full models.
Not investment advice.